Page last updated: 2024-10-23

bencyclane and Hemolysis

bencyclane has been researched along with Hemolysis in 1 studies

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinsella, HC1
Smith, SP1
Spector, RG1

Other Studies

1 other study available for bencyclane and Hemolysis

ArticleYear
Bencyclan: a new drug with unusual membrane stabilising properties in erythrocytes.
    European journal of pharmacology, 1978, Jul-15, Volume: 50, Issue:2

    Topics: Bencyclane; Cycloheptanes; Erythrocyte Membrane; Erythrocytes; Hemolysis; Humans; Hypotonic Solution

1978